SAN DIEGO (AP) — SAN DIEGO (AP) — Arcturus Therapeutics (ARCT) on Monday reported a loss of $13.4 million in its third quarter.
On a per-share basis, the San Diego-based company said it had a loss of 49 cents.
The results topped Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of $1.25 per share.
The pharmaceutical company posted revenue of $17.2 million in the period, also exceeding Street forecasts. Three analysts surveyed by Zacks expected $11.4 million.
Arcturus Therapeutics shares have decreased 48% since the beginning of the year. In the final minutes of trading on Monday, shares hit $8.81, a decline of 55% in the last 12 months.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ARCT at https://www.zacks.com/ap/ARCT
Copyright © 2026 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
